Filter
4392
Filtered Results: 4392
Text search:
efficacy
Featured
Recommendations
436
New Publications
991
Language
Document type
No document type
2292
Guidelines
804
Studies & Reports
656
Manuals
199
Strategic & Response Plan
154
Fact sheets
122
Training Material
84
Situation Updates
27
Resource Platforms
16
Infographics
16
Brochures
12
Online Courses
6
Videos
4
Countries / Regions
Global
167
India
147
Congo, Democratic Republic of
130
Senegal
117
South Africa
85
Kenya
83
Burkina Faso
78
Africa
72
Ethiopia
65
Uganda
64
Western and Central Europe
58
Nigeria
54
Benin
54
Sierra Leone
51
Haiti
51
Latin America and the Carribbean
49
Tanzania
48
West and Central Africa
47
Rwanda
46
Liberia
44
Nepal
42
Zambia
42
Guinea
40
Malawi
40
Cameroon
39
Ghana
34
Russia
34
East and Southern Africa
32
Bangladesh
31
Mali
29
Eastern Europe
27
Zimbabwe
25
Philippines
25
Brazil
25
Indonesia
24
Ukraine
23
South–East Asia Region
23
Côte d’Ivoire / Ivory Coast
22
Madagascar
22
Myanmar / Burma
22
Middle East and North Africa
22
Mozambique
21
Central African Republic
21
Namibia
19
Germany
18
Syria
17
Cambodia
17
Niger
16
Lesotho
15
Botswana
14
Pakistan
13
Chad
13
South Sudan
11
Eswatini/ Swaziland
11
Argentina
10
Asia
10
Eastern Europe and Central Asia
9
USA
8
Togo
8
Sudan
8
Angola
8
Sri Lanka
8
Chile
8
Somalia
7
Peru
7
Laos
7
Jordan
6
Afghanistan
6
Thailand
6
Yemen
6
Western Pacific Region
6
Paraguay
6
Vietnam
6
Guinea-Bissau
5
Iraq
5
China
5
Colombia
5
Italy
5
Tajikistan
5
Georgia
5
United Kingdom
5
Lebanon
4
Burundi
4
Ecuador
4
Venezuela
4
Iran
4
North America
4
France
4
Morocco
3
North Macedonia
3
Mexico
3
Bhutan
3
Armenia
3
Southern Africa
3
Tunisia
3
Turkey
2
Mauritania
2
Papua New Guinea
2
Switzerland
2
Libya
2
Albania
2
Congo-Brazzaville
2
Canada
2
Gabon
2
Portugal
2
Spain
2
Saudi Arabia
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Serbia
1
Honduras
1
Bolivia
1
Greece
1
Fiji
1
Djibouti
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Denmark
1
Belgium
1
Mauritius
1
Algeria
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1506
Clinical Guidelines
469
Public Health
254
Women & Child Health
235
Key Resources
144
Capacity Building
69
Pharmacy & Technologies
54
Toolboxes
COVID-19
514
Mental Health
404
HIV
306
TB
240
AMR
184
Ebola
158
NTDs
151
Rapid Response
145
Pharmacy
139
Caregiver
120
Disability
103
Planetary Health
88
NCDs
83
Refugee
53
Cholera
32
Conflict
31
Global Health Education
30
Polio
24
Natural Hazards
20
Zika
19
Health Financing Toolbox
17
Social Ethics
15
Specific Hazards
12
Health Financing
1
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and ... of the most promising vaccine candidates among the region’s populations.
While current COVID-19 clinical trial activity on the continent is limited, Africa has substantial experience and capabilities to conduct clinical trials for preventative vaccines across a range of diseases, and many organizations on the continent are working tirelessly to help prepare additional trials on potential COVID-19 vaccines. As the number of candidate vaccines in the development pipeline continues to increase, it will be important for organizations responsible for managing clinical trials in the region to partner with vaccine developers to identify potential and appropriate trial locations, provide support to remove any critical obstacles impeding commencement and progress of trials, and to provide oversight ensuring that trials are conducted safely and ethically.
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and ....
3. A therapeutic vaccine to improve TB
treatment outcomes
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
Acupuncture has been practised for more than 2500 years in the Western Pacific Region and has become a global therapeutic method in recent decades. However, it was reportedthat acupuncturists differed by up to 25% in the acupuncture points they used, raising doubts and uncertainty regarding the ... and safety of acupuncture treatment, as well as causing difficulties in the fields of acupuncture research and education.
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated ... against monkeypox in animals. Our aim was to describe the longitudinal clinical course of monkeypox in a high-income setting, coupled with viral dynamics, and any adverse events related to novel antiviral therapies.
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the ... of miltefosine has increased from two to four; and the recommendation for intralesional antimonials is now strong. For mucosal leishmaniasis there is now a strong recommendation for use of pentavalent antimonials with or without oral pentoxifylline. For visceral leishmaniasis, the strong recommendations for use of pentavalent antimonials and amphotericin B deoxycholate are now conditional.
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Human African trypanosomiasis (HAT), or sleeping sickness, is a painful and protracted disease transmitted through the bite of infected tsetse flies and it is found in rural parts of sub-Saharan Africa. Sleeping sickness has two clinical phases but this review focuses only on treatment of the second...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
